Overview
Hiroyuki Takamatsu practices in Kanazawa, Japan. Mr. Takamatsu is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Multiple Myeloma, Aplastic Anemia, Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), and Bone Marrow Transplant.
His clinical research consists of co-authoring 85 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hemolytic Anemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Aplastic AnemiaMr. Takamatsu isDistinguished. Learn about Aplastic Anemia.
- Multiple MyelomaMr. Takamatsu isDistinguished. Learn about Multiple Myeloma.
- Advanced
- AnemiaMr. Takamatsu isAdvanced. Learn about Anemia.
- Bone Marrow TransplantMr. Takamatsu isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- B-Cell LymphomaMr. Takamatsu isExperienced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Takamatsu isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hemolytic AnemiaMr. Takamatsu isExperienced. Learn about Hemolytic Anemia.
- LeukemiaMr. Takamatsu isExperienced. Learn about Leukemia.
- MononucleosisMr. Takamatsu isExperienced. Learn about Mononucleosis.
- Myelodysplastic Syndrome (MDS)Mr. Takamatsu isExperienced. Learn about Myelodysplastic Syndrome (MDS).